Optogenetics identifies receptor linked to cancer, expanding into drug discovery

A team of scientists at the Institute of Science and Technology Austria (IST Austria; Klosterneuburg, Austria) employed optogenetics (the use of light to control genetically modified cells) to identify a new compound that inhibits the orphan receptor ROS1, which has been linked to several forms of cancer. The researchers' work is promising for expanding optogenetics into the field of drug discovery.

Related: Light now able to activate cell surface receptors, with promising implications

The researchers demonstrated the power of optogenetics by carrying out a screen against 'orphan' receptors, the receptors for which the natural ligand is currently unknown. Therefore, orphan receptors can only be activated in cells using a synthetic approach, such as the artificial light switch introduced in their study. Using the optical screening method, the researchers identified a new active compound that binds to and inhibits ROS1, an orphan receptor that plays a role in a variety of cancers. The inhibitory compound AV-951, also known as Tivozanib, has already been studied in clinical trials and has the potential to treat many forms of cancer.

(L-R) Postdoc Álvaro Inglés-Prieto, PhD student Eva Reichhart, and Assistant Professor Harald Janovjak, whose work using optogenetics identified a receptor linked to many forms of cancer
(L-R) Postdoc Álvaro Inglés-Prieto, PhD student Eva Reichhart, and Assistant Professor Harald Janovjak, whose work using optogenetics identified a receptor linked to many forms of cancer.

In the study, the researchers used light as both the activator and the readout of cellular signaling without needing assay chemicals, which limits the number of steps required in carrying out the screen. By using LEDs, activation is both cheap and highly specific.

Full details of the work appear in the journal Nature Chemical Biology; for more information, please visit http://dx.doi.org/10.1038/nchembio.1933.

Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

FDA authorizes emergency use of Zika virus molecular detection assay

The xMAP MultiFLEX Zika RNA assay combines optofluidics and digital signal processing to detect Zika virus in vitro.

'Lab on a stick' test optically and rapidly detects antibiotic resistance

A point-of-care test, based on the dipstick method, can rapidly detect bacterial resistance to antibiotics in urine.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Microscope detects one million-plus biomarkers for sepsis in 30 minutes

A microscope has the potential to simultaneously detect more than one million biomarkers for sepsis at the point of care.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS